Tag Archives: GlaxoSmithKline
-
-
Zantac MDL Judge To Consider Motion to Dismiss Amended Medical Monitoring Class Action
-
Zantac Lawsuits Against GSK, Pfizer and Other Brand Drug Makers Survive Motions to Dimsiss
-
Birth Defect Lawsuits Over Zofran Dismissed After Summary Judgment Granted on Federal Preemption
-
Motions to Dismiss Zantac Recall Lawsuits Are Being Considered By Court During Hearing This Week
-
Following Zantac Recalls, Drug Maker Deleted Emails In Violation of Preservation Orders
-
Following Zantac Problems and Recalls, GlaxoSmithKline Sells Manufacturing Plant In India For Fraction Of Value
-
First Bellwether Trial Over Zofran Birth Defects Set To Begin October 2021
-
GlaxoSmithKline Says FDA Rejection of Petition to Review Zofran Pregnancy Data Should Provide Company Liability Protection
-
Zantac Study Finds Gastrointestinal Cancer Risk Three Times Higher Among Users of Recalled Heartburn Drug